Jennifer Sherr MD, PhD's passion for the care of those with type 1 diabetes (T1D) is quite personal, as she was diagnosed in 1987. From the time of her diagnosis, she was determined to become a pediatric endocrinologist. She completed her undergraduate and medical school training through an accelerated Joint BA/MD program at Rutgers University and the University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School. She then completed both her pediatric residency and pediatric endocrinology fellowship at Yale. While she always wanted to care for those with T1D, her eyes were open to the meaningful impact that clinical research has. She thus embarked on further training through the Yale Graduate School of Arts and Sciences Investigative Medicine Program, a PhD program designed to develop the next generation of physician scientists.

Dr Sherr has been devoted to clinical research over the past 13 years' time. Her thesis examined the mechanisms responsible for the loss of the glucagon response to hypoglycemia and its relationship to residual beta-cell function. Dr Sherr has since focused her career on both clinical therapeutics and technologic advancements including new glucagon formulations, adjunctive therapies for those with T1D, and new technologies including continuous glucose monitors and automated insulin delivery systems. She served as the first Junior Pediatric Faculty Member for the Type 1 Diabetes Exchange (T1DX). As an Associate Professor in the Department of Pediatrics, her goal in both the clinical and research realm is to reduce the burden of living with T1D, for both her patients and herself.